The Drug Enforcement Administration (DEA) is once again in the spotlight, but this time, the messaging feels more conflicted than ever. While the White House has issued directives acknowledging the medicinal value of cannabis and pushing for its rescheduling, the DEA is simultaneously promoting an anti-cannabis video contest aimed at the youth, centered around the upcoming “4/20” holiday.
This mixed messaging raises significant questions about the federal government’s unified stance on cannabis. On one hand, we see a move toward scientific acceptance and policy reform; on the other, we see a continuation of “Just Say No” era tactics that focus heavily on stigmatization.
The “Anti-420” Video Contest
Recently, the DEA has been actively promoting a contest organized by the non-profit group Johnny’s Ambassadors. The “Youth THC Prevention Video PSA Contest” invites high school students to create 30-to-60-second videos warning their peers about the dangers of THC use.
The contest, which closes on April 13, 2026, encourages students to “flood” Instagram with anti-cannabis messaging on April 20, a date traditionally celebrated by cannabis culture. The rules are strict: videos must not depict or imitate the use of marijuana, even as a joke, and must focus on the harms of THC to the developing brain and mental health.
Winners receive cash prizes ranging from $100 to $500. The DEA has leveraged its “Just Think Twice” and “Get Smart About Drugs” platforms to amplify this campaign, signaling its continued alignment with prohibitionist rhetoric despite the shifting legal landscape.
A Conflicting Directive from the Top
What makes this campaign particularly jarring is the current political backdrop. In December 2025, an executive order was signed directing the Attorney General to expeditiously complete the rulemaking process to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA).
This move to Schedule III is a huge shift. It essentially serves as a federal admission that cannabis has “currently accepted medical use”—a direct contradiction to the Schedule I definition that claims it has no medical value and a high potential for abuse.
The executive order highlighted findings from the FDA and HHS, noting that credible scientific support exists for marijuana’s use in treating chronic pain, anorexia, and nausea. By pushing for rescheduling, the administration is acknowledging that cannabis is not the villain it was once painted to be, but rather a substance with legitimate therapeutic applications.
Yet, as the machinery of government grinds toward this historic reform, the DEA’s promotional arm continues to operate as if we are still in the height of the War on Drugs, focusing resources on demonizing a plant that the government itself is in the process of validating.
The “Protect the Youth” Narrative vs. Reality
It is universally agreed that children and teenagers should not be consuming cannabis. The developing brain is sensitive, and responsible regulation always includes strict age verification to keep adult products out of the hands of minors. However, the frustration for many lies in the focus and the framing of these campaigns.
The DEA’s support for this contest implies that cannabis is a primary threat to public safety, yet the data on other substances paints a starkly different picture.
The Silence on Alcohol
According to the CDC, excessive alcohol use leads to approximately 178,000 deaths in the United States each year. Alcohol is widely available, socially celebrated, and advertised during prime-time television.
Yet, we rarely see federal agencies promoting “Anti-Oktoberfest” contests or asking students to flood social media with warnings about the dangers of a Friday night beer.
The Fentanyl Crisis
Even more pressing is the opioid crisis. In 2023 alone, there were an estimated 107,543 drug overdose deaths in the U.S., with synthetic opioids like fentanyl accounting for nearly 75,000 of those fatalities. This is an immediate, lethal threat that is actually killing young people at alarming rates.
While preventing youth cannabis use is a valid goal, allocating resources to an “Anti-420” social media campaign feels like a misalignment of priorities when compared to the tangible devastation caused by alcohol and unregulated synthetic opioids.
Moving Toward Education, Not Stigma
The disconnect between the DEA’s messaging and the White House’s policy direction suggests a federal government at war with itself over cannabis. Rescheduling is moving forward because the science demands it, yet the culture within certain agencies remains stuck in the past.
We can—and should—protect our youth. But we do that through honest, science-based education and regulation, not by encouraging scare tactics or demonizing a plant that millions of adults use responsibly for medicine and relaxation.
As we approach April 20, the conversation shouldn’t just be about “anti-pot” messaging. It should be about demanding consistency from our government. If cannabis has medicinal value—as the rescheduling effort admits—then our educational campaigns should reflect that nuance, rather than treating it with the same severity as lethal narcotics.
